Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.
about
Lysophosphatidylcholine modulates fibril formation of amyloid beta peptidecDNA cloning and expression of intracellular platelet-activating factor (PAF) acetylhydrolase II. Its homology with plasma PAF acetylhydrolase150-kD oxygen-regulated protein is expressed in human atherosclerotic plaques and allows mononuclear phagocytes to withstand cellular stress on exposure to hypoxia and modified low density lipoproteinDisruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient miceAtherosclerosis: process, indicators, risk factors and new hopesRole of advanced glycation end products in cellular signalingDifferential display identification of 40 genes with altered expression in activated human smooth muscle cells. Local expression in atherosclerotic lesions of smags, smooth muscle activation-specific genesAtherogenesis in perspective: hypercholesterolemia and inflammation as partners in crimeThematic review series: the pathogenesis of atherosclerosis: an interpretive history of the cholesterol controversy, part III: mechanistically defining the role of hyperlipidemia4-Hydroxynonenal and cell signallingAtherogenic concentrations of low-density lipoprotein enhance endothelial cell generation of epoxyeicosatrienoic acid productsEvidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and manMitogenic effect of oxidized low-density lipoprotein on vascular smooth muscle cells mediated by activation of Ras/Raf/MEK/MAPK pathwayIron overload diminishes atherosclerosis in apoE-deficient miceThe innate immune response to products of phospholipid peroxidationEffects of silencing leukocyte-type 12/15-lipoxygenase using short interfering RNAsRecognition of solubilized apoproteins from delipidated, oxidized low density lipoprotein (LDL) by the acetyl-LDL receptorEvidence that the lipid moiety of oxidized low density lipoprotein plays a role in its interaction with macrophage receptorsCeruloplasmin enhances smooth muscle cell- and endothelial cell-mediated low density lipoprotein oxidation by a superoxide-dependent mechanism.Lipid oxidation enhances the function of activated protein C.Cholesteryl ester accumulation in macrophages incubated with low density lipoprotein pretreated with cigarette smoke extractLysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesisWhy are low-density lipoproteins atherogenic?Dietary antioxidants, cancer, and atherosclerotic heart disease.Oxidised low density lipoproteins and atherogenesis.Role of oxidised low density lipoprotein in atherogenesisComprehensive metabolomics identified lipid peroxidation as a prominent feature in human plasma of patients with coronary heart diseasesMinimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells.An update on the role of free radicals and antioxidant defense in human disease.Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesionsSphingosine kinase regulates oxidized low density lipoprotein-mediated calcium oscillations and macrophage survivalReactions of *NO, *NO2 and peroxynitrite in membranes: physiological implications.A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoproteinLow density lipoprotein undergoes oxidative modification in vivo.The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68Modified LDL - trigger of atherosclerosis and inflammation in the arterial intima.Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging.Phospholipase A2 activity of low density lipoprotein: evidence for an intrinsic phospholipase A2 activity of apoprotein B-100.Ligation of macrophage Fcγ receptors recapitulates the gene expression pattern of vulnerable human carotid plaquesPreparation of a human standard for determination of the levels of antibodies to oxidatively modified low-density lipoproteins
P2860
Q24323259-45430E42-D753-4342-BD1F-CB5CD9BB4258Q24336429-5A88A526-8417-474B-A171-1D27936F4CA5Q24561945-D4AC8B58-9160-4461-B868-AC44BD097809Q24563208-B01EF22A-37EF-46F6-A73C-FA257C134878Q26822655-9271C595-ADAA-4D7E-BAE4-76D910B4F52DQ27003423-295DC146-B0D2-4C35-ACB6-B72ECAA5F005Q28145016-E1B58ABE-83D5-4BEE-8A07-AC205654EEA9Q28212769-CB54A7F5-7CA6-4540-B765-7D76F4FB64EDQ28259861-26359B6A-8B83-477E-9267-D3603565FA25Q28282283-6BF20A17-F98E-44E5-913F-C9B633FA43E2Q28335393-A58C5800-E167-4074-981B-C5E8CE4FF825Q28359675-CC801583-AEA5-43C3-B3D8-5B16148884F7Q28361224-6FC63F1B-C333-4D6A-ADF4-17B732C07120Q28367084-C4E5E1D6-E016-4AA7-9CD3-DAA08EF78B63Q28389385-48988F01-074B-4F73-84CC-878F9C8CBDD0Q28574130-426755D6-80B3-41BA-9FED-674DBB128FEBQ28678254-79288DAB-94FB-4E71-89D6-BF0D7768CF7FQ28678467-4B9D85B4-9DFD-4D19-A957-F994A6AF6979Q30423997-49C84A06-157F-46C5-89B3-48725A4AEC1AQ31509260-2466B752-71C6-4F45-8AF8-7BD5038997AAQ33564788-13EB5C6C-7EE5-49AC-8D85-90C2ED0DCCA3Q33567912-03AA6000-4986-459E-A3ED-35123F83F19AQ33607440-50940360-6C49-4CCE-9BD8-09EF24C3BC4EQ33608469-1ABACE7E-2C8E-4A20-9361-5C8C811FD46EQ33612896-7C87DCC2-3762-4378-8955-D82E2BA4F0ACQ33613205-536A0140-2BCC-423E-87A1-328952962FABQ33633974-BAEC35AC-C973-43C1-96D1-8C32C130F1EBQ33667974-0171D01E-5978-4560-B89A-7492D7B38AE3Q33704711-43B774DC-B733-42F6-8716-3515E71EB57AQ33783079-0EAC12A3-F8BA-4402-AB12-90095560208FQ33784652-4CD0F05D-72F6-4237-9D75-E5206CF61D7FQ33814364-7B571532-4351-4E60-BA79-22A0B975B23FQ33836010-37433AAB-FED2-480B-812A-25227D182F33Q33838672-15EE93CD-DC17-473F-BD41-2D6C0A6700CCQ33854305-5650EFD9-A3E3-48A5-AFE6-8C5CCFA2E807Q33890396-2C3C4831-E069-4C6E-A954-E188C1279E8AQ33901974-5B817538-3799-4F14-B6A4-DE591AA0DB12Q33925421-EA073DF2-18A4-4954-9480-28531ED67D0EQ33981389-D9F753AC-7B40-496C-8117-B4A0CFC5BA56Q33999608-9DE1D484-81AB-4402-B69A-23411A366B7C
P2860
Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh
1984年學術文章
@zh-hant
name
Modification of low density li ...... ity lipoprotein phospholipids.
@ast
Modification of low density li ...... ity lipoprotein phospholipids.
@en
type
label
Modification of low density li ...... ity lipoprotein phospholipids.
@ast
Modification of low density li ...... ity lipoprotein phospholipids.
@en
prefLabel
Modification of low density li ...... ity lipoprotein phospholipids.
@ast
Modification of low density li ...... ity lipoprotein phospholipids.
@en
P2093
P2860
P356
P1476
Modification of low density li ...... ity lipoprotein phospholipids.
@en
P2093
D Steinberg
J L Witztum
S Parthasarathy
U P Steinbrecher
P2860
P304
P356
10.1073/PNAS.81.12.3883
P407
P577
1984-06-01T00:00:00Z